Cyclacel Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Cyclacel Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $19K, a 7.96% increase year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $19K +$1.4K +7.96% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $17.6K +$2.2K +14.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $15.4K -$86.9K -84.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $102K +$21.6K +26.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $80.7K -$83.4K -50.8% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-12
Q2 2019 $245M* Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $164K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.